Azure Search药品索引结构设计：分类分面实现方案问询

Should I structure my drug index as single rows per search term (brand/generic/indication) or per brand with linked data? #

Great question—let’s break this down based on common search indexing best practices for pharmaceutical tools, since both approaches have tradeoffs depending on your goals.

First, let’s validate your initial idea: Single row per search term

Your proposed structure (one row for each brand, one for each generic name, one for each indication) is totally workable, but it comes with pros and cons:

• Pros: Super straightforward to implement type facets (just filter by a term_type field like "Brand", "Generic", "Indication"). It’s easy to map user queries directly to matching rows without dealing with nested data.
• Cons: Massive index redundancy. For example, a brand like Advil (linked to generic Ibuprofen and indications "pain relief" / "fever reduction") would require 3+ separate rows. This bloat slows down indexing and can lead to duplicate brand entries in search results, forcing you to add extra logic to deduplicate and aggregate related info for users.

The alternative: Brand-centric rows with linked multi-value fields

This is the more common approach for drug search tools, and it’s usually better for user experience and index efficiency:

• How it works: Each row represents a single drug brand, with nested/multi-value fields for its associated generic names and indications. A sample document might look like this (using JSON for clarity):

  {
    "brand_name": "Advil",
    "generic_names": ["Ibuprofen"],
    "indications": ["Pain relief", "Fever reduction"],
    "searchable_text": "Advil Ibuprofen Pain relief Fever reduction"
  }
  

• Pros: No redundancy—each brand is indexed once. Users get a clean, consolidated view of a brand’s full context (what it’s made of, what it treats) in one result. Modern search engines (Elasticsearch, Solr, etc.) natively support multi-value fields for faceting, so you can still build your type facets:
  • For "Brand" facet: Aggregate on brand_name
  • For "Generic" facet: Aggregate on generic_names
  • For "Indication" facet: Aggregate on indications
• Cons: Requires a bit more setup to ensure multi-value fields are properly indexed for search and faceting. But this is a standard feature in most enterprise search tools, so it’s rarely a blocker.

A hybrid middle ground (for maximum flexibility)

If you want the best of both worlds, you can build a unified index that includes both brand-centric documents and "proxy" documents for generics/indications:

• Brand documents: As above, with full linked data
• Generic proxy documents: { "entity_type": "Generic", "name": "Ibuprofen", "linked_brands": ["Advil", "Motrin"] }
• Indication proxy documents: { "entity_type": "Indication", "name": "Pain relief", "linked_brands": ["Advil", "Tylenol"] }

This way:

• Users searching for a generic name or indication land on the proxy document, which can link directly to all relevant brands
• Type facets work seamlessly by filtering on entity_type
• You avoid redundant brand data while keeping search coverage broad

Final Recommendation #

There’s no absolute "correct" answer, but the brand-centric multi-value structure is the default choice for most drug search tools. It’s efficient, user-friendly, and aligns with how people typically look up drugs (users often start with a brand name, then want to know its generic equivalent or use cases). Only use the single-row-per-term approach if your search tool has strict limitations on multi-value fields or faceting.

内容的提问来源于stack exchange，提问作者user3603308